Paysign, Inc. (NASDAQ:PAYS – Get Free Report) saw some unusual options trading activity on Wednesday. Traders purchased 2,581 call options on the company. This represents an increase of 712% compared to the typical volume of 318 call options.
Paysign Stock Down 3.6%
Shares of PAYS stock traded down $0.37 during mid-day trading on Wednesday, hitting $9.77. 490,435 shares of the stock were exchanged, compared to its average volume of 752,638. The firm has a fifty day moving average of $13.82 and a 200 day moving average of $8.63. Paysign has a 52-week low of $3.08 and a 52-week high of $16.15. The company has a market cap of $551.63 million, a PE ratio of 29.61 and a beta of 0.92.
Paysign (NASDAQ:PAYS – Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.02. Paysign had a return on equity of 37.20% and a net margin of 18.48%. The firm had revenue of $30.80 million during the quarter, compared to analyst estimates of $29.02 million. Equities analysts predict that Paysign will post 0.58 EPS for the current year.
Key Stories Impacting Paysign
These are some of the PAYS stories that stood out recently:
- Positive Sentiment: Third-quarter revenue reached a record $30.8 million, up 42.6% year over year. EPS of $0.11 beat the $0.09 consensus, while operating margin more than tripled to 23.8%. Pharma revenue rose 109.8%. Paysign third-quarter results
- Negative Sentiment: FY 2026 EPS guidance of $0.37–$0.38 is below the $0.51 consensus, raising concerns about profitability relative to expectations. Paysign Q3 earnings call transcript
- Negative Sentiment: A customer’s pullback is weighing on expected future revenue, and Maxim Group downgraded PAYS from “buy” to “hold,” adding pressure to the outlook. Customer pullback and future revenue Maxim Group ratings
Insider Activity at Paysign
In other Paysign news, EVP Joan Herman sold 38,900 shares of the company’s stock in a transaction on Wednesday, September 16th. The shares were sold at an average price of $11.74, for a total value of $456,686.00. Following the sale, the executive vice president directly owned 609,421 shares of the company’s stock, valued at approximately $7,154,602.54. This represents a 6.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael Ngo sold 79,925 shares of the company’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $12.74, for a total transaction of $1,018,244.50. Following the completion of the sale, the insider directly owned 2,350,000 shares in the company, valued at approximately $29,939,000. The trade was a 3.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 259,904 shares of company stock worth $3,402,424 over the last three months. Company insiders own 24.50% of the company’s stock.
Institutional Trading of Paysign
Institutional investors have recently bought and sold shares of the business. Legal & General Group Plc purchased a new stake in shares of Paysign in the second quarter valued at approximately $35,000. D.A. Davidson & CO. grew its stake in Paysign by 38.4% in the 3rd quarter. D.A. Davidson & CO. now owns 18,323 shares of the company’s stock valued at $247,000 after acquiring an additional 5,082 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Paysign by 11.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 65,853 shares of the company’s stock worth $389,000 after acquiring an additional 6,717 shares in the last quarter. EFG International AG purchased a new stake in Paysign in the 2nd quarter worth $68,000. Finally, Quantbot Technologies LP purchased a new stake in Paysign in the 2nd quarter worth $97,000. 25.89% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the company. Maxim Group cut Paysign from a “buy” rating to a “hold” rating in a research report on Wednesday. Weiss Ratings raised shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a research note on Thursday, October 8th. Barrington Research set a $15.00 price objective on shares of Paysign in a research note on Tuesday, August 11th. Lake Street Capital lifted their target price on shares of Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a report on Tuesday, September 15th. Finally, Wall Street Zen cut shares of Paysign from a “strong-buy” rating to a “buy” rating in a research note on Sunday, August 16th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $15.00.
View Our Latest Stock Analysis on PAYS
About Paysign
Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.
Further Reading
- Five stocks we like better than Paysign
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
- Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand
- Alphabet Escalates AI Chip Rivalry With NVIDIA
- Amazon’s Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.
